Search Medical Condition
Please enter condition
Please choose location
 

Culiacan, Mexico Clinical Trials

A listing of Culiacan, Mexico clinical trials actively recruiting patients volunteers.

RESULTS

Found (54853) clinical trials

Evaluate the potential effect of hepatic or renal impairment on the pharmacokinetics, safety and tolerability of BAY 1841788 (ODM-201).

Phase

This study will be conducted in 2 parts. The phase 1b part will be an international, phase 1b, open-label, dose-escalation assessment of radium-223 dichloride administered with bortezomib and dexamethasone in subjects with relapsed multiple myeloma. The primary endpoint is to determine the optimal dose of radium-223 dichloride in combination with ...

Phase

People with arteriovenous fistula are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

People with Influenza A are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

We are conducting a research study comparing the effects of an investigational general albuterol drug to a marketed albuterol drug called ProAir.

Phase N/A

ICON Early Phase Services is conducting a research study for healthy adults ages 18-55 inclusive. This study is being done to test a new formulation of an approved pain medication. The study drugs will be administered orally.  Vital signs, ECGs, physical examinations and pregnancy, drug and alcohol screens will be ...

Phase

The purpose of this study is to evaluate itacitinib or placebo in combination with corticosteroids as first-line treatment of participants with Grade II to IV acute graft-versus-host disease (aGVHD).

Phase

We are conducting a study to find out if an investigational vaccine prevents severe diarrhea caused by a germ (bacterium) called Clostridium difficile (C diff) in subjects 50 year of age and older.

Phase

The primary goal is to address several key treatment and management issues surrounding patients with either AIS or ICH on anticoagulant therapy. In particular, attention will be focused on coagulation tests, utilization of thrombolytic therapy for AIS, treatment patterns and clinical outcomes for AIS and ICH patients on anticoagulant therapy.

Phase N/A

MaRISS is a prospective observational study to define the 90-day outcomes of patients with mild and/or rapidly improving stroke by a telephone-based assessment of stroke outcomes based on established and validated measures including the mRS, BI, SIS-16 and EuroQOL. The efficacy and safety outcomes of patients with mild and improving ...

Phase N/A